Cytokinetics Inc vs Manchester United PLC — how do they compare? Cytokinetics Inc trades at $76.61 (market cap $10.63B), while Manchester United PLC trades at $22.23 (market cap $3.80B). The key difference: Cytokinetics Inc is far larger — about 2.8× Manchester United PLC's market cap, and Manchester United PLC pays a 1.26% dividend while Cytokinetics Inc pays none. Which is the better fit depends on your goals.
| CYTK | MANU | |
|---|---|---|
Market Cap | $10.63B | $3.80B |
Sector | Technology | Media |
52-Week High | $87.26 | $23.53 |
52-Week Low | $34.31 | $15.10 |
Enterprise Value | $10.74B | $4.74B |
Dividend Yield | — | 1.26% |
Trailing returns across standard periods
Cytokinetics is a biopharmaceutical company focused on muscle biology. It develops muscle activators and inhibitors as potential treatments for debilitating diseases where muscle performance is compromised or declining.
Read more on CYTK →Manchester United PLC operates a professional football club together with related and ancillary activities. The company manages the soccer team and all affiliated club activities of the Manchester United Football Club, which includes the media network, foundation, fan zone, news, sports features, and team merchandise. Manchester United is based in England. The company has three principal sectors from which most of the revenue is generated, including Commercial, Broadcasting, and Matchday.
Read more on MANU →